{
  "resourceType" : "ValueSet",
  "id" : "ATCImmunotherapyCLL",
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet ATCImmunotherapyCLL</b></p><a name=\"ATCImmunotherapyCLL\"> </a><a name=\"hcATCImmunotherapyCLL\"> </a><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href=\"CodeSystem-GenericValues.html\"><code>https://kip.rkkp.dk/fhir/CodeSystem/GenericValues</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-GenericValues.html#GenericValues-none\">none</a></td><td>Ingen immunterapi</td><td>None - used to choose none of the available values</td></tr><tr><td><a href=\"CodeSystem-GenericValues.html#GenericValues-other\">other</a></td><td>Andet</td><td>Other - used to choose unspecific value not in a valueset</td></tr></table></li><li>Include these codes as defined in <a href=\"CodeSystem-ATC.html\"><code>https://kip.rkkp.dk/fhir/CodeSystem/ATC</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L04AA34\">L04AA34</a></td><td>Alemtuzumab</td><td>L04AA34 - alemtuzumab</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01FA01\">L01FA01</a></td><td>Rituximab</td><td>L01FA01 - rituximab</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01FA02\">L01FA02</a></td><td>Ofatumumab</td><td>L01FA02 - ofatumumab</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01FA03\">L01FA03</a></td><td>Obinutuzumab</td><td>L01FA03 - obinutuzumab</td></tr></table></li></ul></div>"
  },
  "url" : "https://kip.rkkp.dk/fhir/ValueSet/ATCImmunotherapyCLL",
  "version" : "2.12.2",
  "name" : "ATCImmunotherapyCLL",
  "title" : "ATC_CLL_immunterapi",
  "status" : "active",
  "experimental" : true,
  "date" : "2022-07-13T00:00:00+02:00",
  "publisher" : "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
  "contact" : [{
    "name" : "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
    "telecom" : [{
      "system" : "url",
      "value" : "https://trifork.com"
    },
    {
      "system" : "email",
      "value" : "rbk@trifork.com"
    }]
  }],
  "description" : "ATC koder immunterapi - [CLL]",
  "compose" : {
    "include" : [{
      "system" : "https://kip.rkkp.dk/fhir/CodeSystem/GenericValues",
      "concept" : [{
        "code" : "none",
        "display" : "Ingen immunterapi"
      },
      {
        "code" : "other",
        "display" : "Andet"
      }]
    },
    {
      "system" : "https://kip.rkkp.dk/fhir/CodeSystem/ATC",
      "concept" : [{
        "code" : "L04AA34",
        "display" : "Alemtuzumab"
      },
      {
        "code" : "L01FA01",
        "display" : "Rituximab"
      },
      {
        "code" : "L01FA02",
        "display" : "Ofatumumab"
      },
      {
        "code" : "L01FA03",
        "display" : "Obinutuzumab"
      }]
    }]
  }
}